FEIBA-NF factor VIII inhibitor bypassing fraction 2500U powder for injection vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

feiba-nf factor viii inhibitor bypassing fraction 2500u powder for injection vial with diluent vial

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 1000 mg - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

Haemate P 1200 IU vWF/500 IU FVIII 1200 IU - 500 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

haemate p 1200 iu vwf/500 iu fviii 1200 iu - 500 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - human factor von willebrand 1200 iu; human coagulation factor viii 500 iu - powder and solvent for solution for injection/infusion - 1200 iu - 500 iu - human coagulation factor viii 500 iu; factor von willebrand 1200 iu - von willebrand factor and coagulation factor viii in combination

Haemate P 2400 IU vWF/1000 IU FVIII 2400 IU - 1000 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

haemate p 2400 iu vwf/1000 iu fviii 2400 iu - 1000 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - human factor von willebrand 2400 iu; human coagulation factor viii 1000 iu - powder and solvent for solution for injection/infusion - 2400 iu - 1000 iu - human coagulation factor viii 1000 iu; factor von willebrand 2400 iu - von willebrand factor and coagulation factor viii in combination

Haemate P 600 IU vWF/250 IU FVIII 600 IU - 250 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

haemate p 600 iu vwf/250 iu fviii 600 iu - 250 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - human coagulation factor viii 250 iu; human factor von willebrand 600 iu - powder and solvent for solution for injection/infusion - 600 iu - 250 iu - human coagulation factor viii 250 iu; factor von willebrand 600 iu - von willebrand factor and coagulation factor viii in combination

Wilate 1000,1000 IU FVIII/1000 IU VWF inj. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

wilate 1000,1000 iu fviii/1000 iu vwf inj. sol. (pwdr. + solv.) i.v. vial

octapharma benelux sa-nv - human coagulation factor viii 1000 iu; human factor von willebrand 1000 iu - powder and solvent for solution for injection - factor von willebrand 100 iu/ml; human coagulation factor viii 100 iu/ml - von willebrand factor and coagulation factor viii in combination

Wilate 500,500 IU FVIII/500 IU VWF inj. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

wilate 500,500 iu fviii/500 iu vwf inj. sol. (pwdr. + solv.) i.v. vial

octapharma benelux sa-nv - human factor von willebrand 500 iu; human coagulation factor viii 500 iu - powder and solvent for solution for injection - factor von willebrand 100 iu/ml; human coagulation factor viii 100 iu/ml - von willebrand factor and coagulation factor viii in combination

OPTIVATE 500 I.U Israel - English - Ministry of Health

optivate 500 i.u

kamada ltd, israel - factor viii; von willebrand factor - powder for solution for injection - factor viii 500 iu/vial; von willebrand factor 1300 iu/vial - von willebrand factor and coagula-tion factor viii in combination - von willebrand factor and coagula-tion factor viii in combination - treatment and prophylaxis of bleeding with haemophilia a (congenital factor viii deficiency).

OPTIVATE 1000 I.U Israel - English - Ministry of Health

optivate 1000 i.u

kamada ltd, israel - factor viii; von willebrand factor - powder for solution for injection - factor viii 1000 iu/vial; von willebrand factor 2600 iu/vial - von willebrand factor and coagula-tion factor viii in combination - von willebrand factor and coagula-tion factor viii in combination - treatment and prophylaxis of bleeding with haemophilia a (congenital factor viii deficiency).

WILATE 1000/1000 International Unit Pdr+Solv for Soln for Inj Ireland - English - HPRA (Health Products Regulatory Authority)

wilate 1000/1000 international unit pdr+solv for soln for inj

octapharma limited - factor viii (antihaemophilic factor), von willebrand factor human - pdr+solv for soln for inj - 1000/1000 international unit - blood coagulation factors

WILATE 500/500 International Unit Pdr+Solv for Soln for Inj Ireland - English - HPRA (Health Products Regulatory Authority)

wilate 500/500 international unit pdr+solv for soln for inj

octapharma limited - factor viii (antihaemophilic factor), von willebrand factor human - pdr+solv for soln for inj - 500/500 international unit - blood coagulation factors